Phreesia, Inc.
About Phreesia, Inc.
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2026
- $467.8M
- Net income
- $2.3M
- Total assets
- $663.8M
- Market cap
- $589.7M
- Operating margin
- -1.4%
- Net margin
- 0.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $480.6M
- Operating expenses
- $487.2M
- Operating income
- -$6.6M
- Income tax
- -$11.2M
- Net income
- $2.3M
- EPS (basic)
- $0.04
- EPS (diluted)
- $0.04
Balance sheet
- Total assets
- $663.8M
- Current assets
- $279.8M
- Total liabilities
- $326.6M
- Current liabilities
- $183.2M
- Shareholders’ equity
- $337.2M
Cash flow
- Operating cash flow
- $78.8M
- Investing cash flow
- -$161.9M
- Financing cash flow
- $72.9M
- Net cash flow
- -$10.4M
Statements via Polygon.io (SEC filings)
- Market cap
- $589.7M
- P/E ratio
- 233.5
- EPS (diluted)
- $0.04
- Shares outstanding
- 63.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 18, 2019
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $2.3M in FY2026.
- Revenue grew 125% from FY2022 to FY2026.
- Trading 71% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 233.5.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Phreesia, Inc..
Write a review
News about Phreesia, Inc.
News & sentiment via Polygon.io